Evidence map›Paper›PMID 34613520›Full record

ArticleWiener medizinische Wochenschrift (1946)2022

Rare manifestation of a large stenosing gastrointestinal tumor caused by Mycobacterium tuberculosis in a previously healthy man from Austria.

Guangyu Shao, Bakari Chitechi, Gamze Demireli, Karoline Ornig, Matthias J Neuböck, Sven Heldt, Michael Mandl, Christian Paar, Markus Winkler, Bernd Lamprecht and 1 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Wiener medizinische Wochenschrift (1946), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Guangyu ShaoDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria.
Bakari ChitechiDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria.
Gamze DemireliDepartment of General Surgery, Kepler University Hospital, Linz, Austria.
Karoline OrnigInstitute of Pathology, Kepler University Hospital, Linz, Austria.
Matthias J NeuböckDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria.
Sven HeldtDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria.
Michael MandlDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria.
Christian PaarInstitute of Laboratory Medicine, Kepler University Hospital, Linz, Austria.
Markus WinklerInstitute of Pathology, Kepler University Hospital, Linz, Austria.
Bernd LamprechtDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria.
Helmut J F SalzerDepartment of Pulmonary Medicine, Kepler University Hospital, Krankenhausstr. 9, 4021, Linz, Austria. helmut.salzer@kepleruniklinikum.at.
Kepler Universitätsklinikum · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastrointestinal tuberculosis (TB) is a rare manifestation in low TB-incidence countries such as Austria. It is usually seen in immunocompromised patients or in migrants being more susceptible for extrapulmonary disease manifestations. CASE DESCRIPTION: We report a very rare manifestation of severe gastrointestinal TB in a 49-year-old previously healthy man from Upper Austria. Endoscopy showed a large tumor mass obstructing about 2/3 of the lumen of the cecum. Positron emission tomography/computed tomography scan revealed not only a high metabolic activity in the tumor mass, but also active pulmonary lesions in both upper lung lobes. Bronchial secretion showed acid-fast bacilli in the microscopy and polymerase chain reaction was positive for M. tuberculosis complex. Phenotypic resistance testing showed no resistance for first-line anti-TB drugs. Treatment with isoniazid, rifampicin, pyrazinamide and ethambutol was initiated. Based on therapeutic drug monitoring, the standard treatment regime was adapted to rifampicin high dose. TB treatment was well tolerated and the patient achieved relapse-free cure one year after the end of treatment.

conclusionGastrointestinal involvement mimicking an intestinal tumor is a very rare TB manifestation in previously healthy Austrians. However, it should be kept in mind due to increasing migration from countries with higher rates of extrapulmonary TB and due to an increasing number of immunocompromised patients. TB telephone consultations can support medical professionals in the diagnosis and the management of complex TB patients. TB management is currently at a transitional stage from a programmatic to personalized management concept including therapeutic drug monitoring or biomarker-guided treatment duration to achieve relapse-free cure.

Indexed as

Gastrointestinal NeoplasmsMycobacterium tuberculosisAustriaHumansMaleMiddle AgedNeoplasm Recurrence, LocalRifampinRifampinCecumEuropeExtrapulmonary tuberculosisTBTelephone consultation

Identifiers

PMID34613520
PMCPMC9463224
OpenAlexW3204398307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.